Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Keytruda

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Keytruda was produced by Merck & Co..

J&J bags FDA breakthrough designation for prostate cancer drug

J&J bags FDA breakthrough designation for prostate cancer drug Also looking to enter the prostate cancer area is Merck &Co’s blockbuster PD-1 inhibitor Keytruda, which is  currently being studied in patients with mCRPC.

NICE turns down Roche’s Tecentriq for triple-negative breast cancer

NICE turns down Roche’s Tecentriq for triple-negative breast cancer So far Tecentriq’s rivals in the checkpoint inhibitor category – including Merck &Co/MSD’s  Keytruda (pembrolizumab) – have failed to match its results in TNBC, making it the only immunotherapy option ... Keytruda has however shown promise when

BMS plugs on with Opdivo plus Yervoy in first-line NSCLC

BMS plugs on with Opdivo plus Yervoy in first-line NSCLC currently dominated by rival checkpoint inhibitor Keytruda from Merck/MSD. . ... It’s hoping to convince oncologists that a double cancer immunotherapy approach could be a better option than Keytruda plus chemo, which is widely prescribed for

Innate Pharma and AstraZeneca take monalizumab into phase 3

Innate Pharma and AstraZeneca take monalizumab into phase 3 AZ has been seeking Imfinzi combinations which could help it gain on earlier-to-market rivals in the checkpoint inhibitor category, including Merck &Co’s Keytruda and Bristol-Myers Squibb’s

France’s Innate Pharma eyes $100m Nasdaq IPO

France’s Innate Pharma eyes $100m Nasdaq IPO AZ has been looking at combinations for Imfinzi that could help it catch up with earlier-to-market rivals in the checkpoint inhibitor category such as Merck &Co's Keytruda and

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics